Musculoskeletal aging

Current Opinion in Rheumatology

Volumn 16, Issue 2, 2004, Pages 114-118

  Leveille, Suzanne G ^a,b  

^a RESEARCH AND TRAINING INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Arthritis; Economic burden; Musculoskeletal aging; Osteoporosis; Sarcopenia

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PARATHYROID HORMONE; THIAZIDE DIURETIC AGENT;

AGING; ARTHRITIS; ARTHROPATHY; BLEEDING; BONE DENSITY; CHRONIC DISEASE; CLINICAL TRIAL; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DENSITOMETRY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; ETHNIC DIFFERENCE; FRAGILITY FRACTURE; GASTROINTESTINAL DISEASE; HEALTH CARE COST; HIP FRACTURE; HUMAN; KNEE PAIN; LOW DRUG DOSE; MUSCLE ATROPHY; MUSCULOSKELETAL SYSTEM; MYALGIA; OSTEOARTHRITIS; OSTEOPOROSIS; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; RISK FACTOR; SELF CARE; SKELETAL MUSCLE; THROMBOSIS; ULCER; UNITED STATES; VERTEBRA FRACTURE;

AGED; AGING; HIP FRACTURES; HUMANS; MUSCULOSKELETAL PHYSIOLOGIC PROCESSES; OSTEOARTHRITIS; OSTEOPOROSIS; PAIN; PREVALENCE; SELF CARE;

EID: 1442348199     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200403000-00007     Document Type: Review

References (39)

1. Prevalence of self-reported arthritis or chronic joint symptoms among adults - United States, 2001. MMWR Morb Mortal Wkly Rep 2002, 51:948-950.
2. Public health and aging: projected prevalence of self-reported arthritis or chronic joint symptoms among persons aged > 65 years - United States, 2005-2030. MMWR Morb Mortal Wkly Rep 2003, 52:489-491. This analysis has important implications for the rapidly aging US population.
3. Jordan JM, Lawrence R, Kington R, et al.: Ethnic health disparities in arthritis and musculoskeletal diseases: report of a scientific conference. Arthritis Rheum 2002, 46:2280-2286.
4. Zhang Y, Xu L, Nevitt MC, et al.: Lower prevalence of hand osteoarthritis among Chinese subjects in Beijing compared with white subjects in the United States: the Beijing Osteoarthritis Study. Arthritis Rheum 2003, 48:1034-1040. This paper presents a well-conducted comparison of two populations for prevalence of radiographic and symptomatic hand OA.
5. Felson DT, Nevitt MC, Zhang Y, et al.: High prevalence of lateral knee osteoarthritis in Beijing Chinese compared with Framingham Caucasian subjects. Arthritis Rheum 2002, 46:1217-1222.
6. Mannoni A, Briganti MP, Di Bari M, et al.: Epidemiological profile of symptomatic osteoarthritis in older adults: a population based study in Dicomano, Italy. Ann Rheum Dis 2003, 62:576-578.
7. Picavet HS, Hazes JM: Prevalence of self reported musculoskeletal diseases is high. Ann Rheum Dis 2003, 62:644-650.
8. Felson DT, Lawrence RC, Dieppe PA, et al.: Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 2000, 133:635-646.
9. Bergink AP, van Meurs JB, Loughlin J, et al.: Estrogen receptor alpha gene haplotype is associated with radiographic osteoarthritis of the knee in elderly men and women. Arthritis Rheum 2003, 48:1913-1922.
10. Page WF, Hoaglund FT, Steinbach LS, et al.: Primary osteoarthritis of the hip in monozygotic and dizygotic male twins. Twin Res 2003, 6:147-151.
11. 10a Hunter DJ, Snieder H, March L, et al.: Genetic contribution to cartilage volume in women: A classical twin study. Rheumatology Advance Access; June 27, 2003. DOI 10.1093/rheumatology/keg400.
12. Buist DS, LaCroix AZ, Manfredonia D, et al.: Identifying postmenopausal women at high risk of fracture in populations: a comparison of three strategies. J Am Geriatr Soc 2002, 50:1031-1038. This is an excellent presentation of the controversy about screening recommendations for postmenopausal women.
13. Ahlborg HG, Johnell O, Turner CH, et al.: Bone loss and bone size after menopause. N Engl J Med 2003, 349:327-334.
14. Melton LJ 3rd, Crowson CS, O'Fallon WM, et al.: Relative contributions of bone density, bone turnover, and clinical risk factors to long-term fracture prediction. J Bone Miner Res 2003, 18:312-318.
15. Braithwaite RS, Col NF, Wong JB: Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc 2003, 51:364-370.
16. Finkelstein JS, Hayes A, Hunzelman JL, et al.: The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 2003, 349:1216-1226. This is very important work that improves treatment options for persons with osteoporosis.
17. Black DM, Greenspan SL, Ensrud KE, et al.: The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 2003, 349:1207-1215. This is very important work that improves treatment options for persons with osteoporosis.
18. LaCroix AZ, Ott SM, Ichikawa L, et al.: Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000, 133:516-526.
19. Schoofs MW, van der Klift M, Hofman A, et al.: Thiazide diuretics and the risk for hip fracture. Ann Intern Med 2003, 139:476-482.
20. Neuner JM, Zimmer JK, Hamel MB: Diagnosis and treatment of osteoporosis in patients with vertebral compression fractures. J Am Geriatr Soc 2003, 51:483-491.
21. Andrade SE, Majumdar SR, Chan KA, et al.: Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med 2003, 163:2052-2057.
22. Baumgartner RN, Koehler KM, Gallagher D, et al.: Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998, 147:755-763.
23. Iannuzzi-Sucich M, Prestwood KM, Kenny AM: Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol Biol Sci Med Sci 2002, 57:M772-M777. This is important research in a new area of study.
24. Melton LJ 3rd, Khosla S, Crowson CS, et al.: Epidemiology of sarcopenia. J Am Geriatr Soc 2000, 48:625-630.
25. Payette H, Roubenoff R, Jacques P, et al.: Insulin-like growth factor-1 and interleukin-6 predict sarcopenia in very old community-living men and women: the Framingham Heart Study. J Am Geriatr Soc 2003, 51:1237-1243. This is a key study examining the etiology of sarcopenia.
26. Pedersen M, Bruunsgaard H, Weis N, et al.: Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. Mech Ageing Dev 2003, 124:495-502.
27. Ferrucci L, Penninx BW, Volpato S, et al.: Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 2002, 50:1947-1954.
28. Picavet HS, Vlaeyen JW, Schouten JS: Pain catastrophizing and kinesiophobia: predictors of chronic low back pain. Am J Epidemiol 2002, 156:1028-1034.
29. Leveille SG, Fried L, Guralnik JM: Disabling symptoms: what do older women report? J Gen Intern Med 2002, 17:766-773.
30. Dunlop DD, Manheim LM, Song J, et al.: Health care utilization among older adults with arthritis. Arthritis Rheum 2003, 49:164-171.
31. Hochberg MC, Altman RD, Brandt KD, et al.: Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum 1995, 38:1541-1546.
32. Rahme E, Marentette MA, Kong SX, et al.: Use of NSAIDs, COX-2 inhibitors, and acetaminophen and associated coprescriptions of gastroprotective agents in an elderly population. Arthritis Rheum 2002, 47:595-602.
33. Spiegel BM, Targownik L, Dulai GS, et al.: The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis. Ann Intern Med 2003, 138:795-806.
34. Strand V, Hochberg MC: The risk of cardiovascular thrombotic events with selective cyclooxygenase-2 inhibitors. Arthritis Rheum 2002, 47:349-355.
35. Solomon DH, Warsi A, Brown-Stevenson T, et al.: Does self-management education benefit all populations with arthritis? A randomized controlled trial in a primary care physician network. J Rheumatol 2002, 29:362-368.
36. Lorig K, Lubeck D, Kraines RG, et al.: Outcomes of self-help education for patients with arthritis. Arthritis Rheum 1985, 28:680-685.
37. Long KR, Mazonson PD, Holman HR: Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs. Arthritis Rheum 1993, 36:439-446.
38. Fries JF, Lorig K, Holman HR: Patient self-management in arthritis? Yes! J Rheumatol 2003, 30:1130-1132.
39. Warsi A, LaValley MP, Wang PS, et al.: Arthritis self-management education programs: a meta-analysis of the effect on pain and disability. Arthritis Rheum 2003, 48:2207-2213.